We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Scientific Presents Latest Innovation in High Volume ESR Testing

By LabMedica International staff writers
Posted on 12 Nov 2024

ALCOR Scientific (Smithfield, RI, USA) is attending MEDICA 2024 in Düsseldorf, the world’s largest event for the medical sector, where the company is presenting its latest innovations in high-volume erythrocyte sedimentation rate (ESR) testing. More...

At this year’s MEDICA, ALCOR is presenting its new iSED PRO fully automated ESR analyzer with a bi-directional interface that is designed to streamline ESR testing for busy, high-volume reference laboratories. The iSED PRO analyzer is rack-compatible and fully automated, significantly reducing the hands-on time and turnaround time required to produce an ESR result. Results are generated in seconds using a small blood sample, allowing for multiple hematology tests to be run off the same primary tube sample. iSED PRO is designed for maximum throughput while offering the flexibility to accommodate each laboratory’s unique workflow.

Among its versatile family of ESR solutions, ALCOR is also showcasing the iSED and iSED ELITE ESR analyzers which are typically suited for medium-high volume labs. These analyzers significantly improve ESR testing efficiency by generating results in seconds with the most automated ESR testing process. These automated, compact benchtop systems enable moderately complex urgent care labs to easily generate truly STAT ESR results in seconds with a small sample volume. Also on display at the trade show is the miniiSED ESR analyzer that helps urgent care centers to bring more testing services in-house. The miniiSED ESR is a compact benchtop analyzer that can generate truly STAT ESR results in seconds from a small sample volume. This allows practices to have results available during a patient visit which can positively impact patient care as well as patient satisfaction, particularly in a rheumatology practice. Operationally, miniiSED can enhance efficiency helping reduce send-out tests and allowing for more tests to be performed with one primary tube sample (compared to other ESR methods that require larger sample volumes).

Related Links:
ALCOR Scientific


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Latex Test
SLE-Latex Test
New
STI Test
RIDA GENE STI Mycoplasma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.